End-to-end Integrated Solutions and Tools for iPSC & Stem Cell Research
With high-impact technologies, we offer complete service platforms and multipurpose products. ASC holds the required licensing to generate, genetically modify, and differentiate iPSCs. Additionally, we use two powerful gene-editing tools, CRISPR and TARGATTTM to engineer cell lines and animal models; generate bioproduction CHO cells and transgenic animals; and produce allogeneic products. Together, these powerful tools allow us to support the current needs of the research community, but we actively work to augment our development and manufacturing capacity to provide greater iPSC-derived product solutions for the biotechnology industry.
Induced Pluripotent Stem Cell Technologies
Complete iPSC Service Platform